|
TADA2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00100047642593E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.07079958420331E-10 |
| Normal-vs-Stage2 |
2.1390000000121E-06 |
| Normal-vs-Stage3 |
1.87439999999039E-06 |
| Normal-vs-Stage4 |
9.72689999999554E-05 |
| Stage1-vs-Stage2 |
9.628800E-01 |
| Stage1-vs-Stage3 |
2.985800E-01 |
| Stage1-vs-Stage4 |
8.230000E-01 |
| Stage2-vs-Stage3 |
3.941200E-01 |
| Stage2-vs-Stage4 |
7.769400E-01 |
| Stage3-vs-Stage4 |
6.816200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.18950462999624E-11 |
| Normal-vs-AfricanAmerican |
4.29049999972619E-07 |
| Normal-vs-Asian |
2.23339999999572E-05 |
| Caucasian-vs-AfricanAmerican |
3.631400E-01 |
| Caucasian-vs-Asian |
4.515000E-01 |
| AfricanAmerican-vs-Asian |
2.774400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.04060015948937E-10 |
| Normal-vs-Female |
1.06980002634316E-09 |
| Male-vs-Female |
4.555000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.96329999322143E-09 |
| Normal-vs-Extreme_Weight |
1.63300000188826E-08 |
| Normal-vs-Obese |
5.79550000212592E-08 |
| Normal-vs-Extreme_Obese |
7.743600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.617400E-01 |
| Normal_Weight-vs-Obese |
1.896170E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.230040E-01 |
| Extreme_Weight-vs-Obese |
8.562000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.654800E-01 |
| Obese-vs-Extreme_Obese |
3.736800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.09060000048112E-07 |
| Normal-vs-Age(41-60Yrs) |
4.40849999838733E-08 |
| Normal-vs-Age(61-80Yrs) |
5.23759924320188E-11 |
| Normal-vs-Age(81-100Yrs) |
6.55859999976194E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.844430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.952800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.577200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.478400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.222420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.092800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.34270000568182E-09 |
| Normal-VS-Type2 PRCC |
5.43019962329083E-10 |
| Normal-VS-KIRP CIMP |
1.26749999385112E-09 |
| Normal-VS-Unclassified PRCC |
1.76375999999534E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.420230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.248070E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.541600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.661900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.824000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.153830E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.79181147486452E-12 |
| Normal-vs-N1 |
5.57350000000012E-05 |
| Normal-vs-N2 |
2.04689999999674E-05 |
| N0-vs-N1 |
6.783200E-01 |
| N0-vs-N2 |
2.007800E-01 |
| N1-vs-N2 |
3.075400E-01 |
|
|
